Morning Overview on MSN
CRISPR revives ancient gene to block gout and fatty liver
Reviving an ancient human gene that prevents gout and fatty liver disease, scientists at Georgia State University have marked ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred. Intellia is working with experts to create a risk management program for nex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results